BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31948940)

  • 21. Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development.
    Tao T; Liu D; Liu C; Xu B; Chen S; Yin Y; Ang L; Huang Y; Zhang X; Chen M
    Biochim Biophys Acta; 2014 Sep; 1839(9):858-65. PubMed ID: 25017995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancer of zeste homolog 2 expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma: a comparative study and review of the literature.
    Xu B; Abourbih S; Sircar K; Kassouf W; Mansure JJ; Aprikian A; Tanguay S; Brimo F
    Arch Pathol Lab Med; 2013 Oct; 137(10):1326-36. PubMed ID: 24079759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
    Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
    Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel variant in the FBP1 gene causes fructose-1,6-bisphosphatase deficiency through increased ubiquitination.
    Liang X; Liu X; Li W; Zhang L; Zhang B; Lai G; Zhao Y
    Arch Biochem Biophys; 2023 Jul; 742():109619. PubMed ID: 37142076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
    Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
    Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder.
    Hinz S; Kempkensteffen C; Christoph F; Hoffmann M; Krause H; Schrader M; Schostak M; Miller K; Weikert S
    J Cancer Res Clin Oncol; 2008 Mar; 134(3):331-6. PubMed ID: 17694325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation.
    Qi Y; Zhang X; Kang Y; Wu J; Chen J; Li H; Guo Y; Liu B; Shao Z; Zhao X
    Mol Biosyst; 2015 Jul; 11(7):1980-6. PubMed ID: 25947258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reciprocal negative feedback loop between EZH2 and miR-101-1 contributes to miR-101 deregulation in hepatocellular carcinoma.
    Huang D; Wang X; Zhuang C; Shi W; Liu M; Tu Q; Zhang D; Hu L
    Oncol Rep; 2016 Feb; 35(2):1083-90. PubMed ID: 26718325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors.
    Huang X; Yan J; Zhang M; Wang Y; Chen Y; Fu X; Wei R; Zheng XL; Liu Z; Zhang X; Yang H; Hao B; Shen YY; Su Y; Cong X; Huang M; Tan M; Ding J; Geng M
    Cell; 2018 Sep; 175(1):186-199.e19. PubMed ID: 30220457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional and therapeutic significance of EZH2 in urological cancers.
    Liu X; Wu Q; Li L
    Oncotarget; 2017 Jun; 8(23):38044-38055. PubMed ID: 28410242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.
    Chen Y; Lin MC; Yao H; Wang H; Zhang AQ; Yu J; Hui CK; Lau GK; He ML; Sung J; Kung HF
    Hepatology; 2007 Jul; 46(1):200-8. PubMed ID: 17596871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased FBP1 expression rewires metabolic processes affecting aggressiveness of glioblastoma.
    Son B; Lee S; Kim H; Kang H; Jeon J; Jo S; Seong KM; Lee SJ; Youn H; Youn B
    Oncogene; 2020 Jan; 39(1):36-49. PubMed ID: 31444412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fructose‑1,6‑bisphosphatase‑1 decrease may promote carcinogenesis and chemoresistance in cervical cancer.
    Li H; Li M; Pang Y; Liu F; Sheng D; Cheng X
    Mol Med Rep; 2017 Dec; 16(6):8563-8571. PubMed ID: 28990097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fructose-1,6-bisphosphatase 1 dephosphorylates IκBα and suppresses colorectal tumorigenesis.
    Zhu W; Chu H; Zhang Y; Luo T; Yu H; Zhu H; Liu Y; Gao H; Zhao Y; Li Q; Wang X; Li G; Yang W
    Cell Res; 2023 Mar; 33(3):245-257. PubMed ID: 36646759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma.
    Wang Y; Wang M; Wei W; Han D; Chen X; Hu Q; Yu T; Liu N; You Y; Zhang J
    Oncotarget; 2016 Aug; 7(31):49450-49458. PubMed ID: 27385092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells.
    Zhan M; Wen F; Liu L; Chen Z; Wei H; Zhou H
    Tumour Biol; 2016 Aug; 37(8):11237-47. PubMed ID: 26945572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect.
    Yang J; Wang C; Zhao F; Luo X; Qin M; Arunachalam E; Ge Z; Wang N; Deng X; Jin G; Cong W; Qin W
    Carcinogenesis; 2017 Feb; 38(2):134-143. PubMed ID: 27742690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.